GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Lunit Inc (XKRX:328130) » Definitions » Earnings per Share (Diluted)

Lunit (XKRX:328130) Earnings per Share (Diluted) : ₩-4,261.00 (TTM As of Mar. 2025)


View and export this data going back to 2022. Start your Free Trial

What is Lunit Earnings per Share (Diluted)?

Lunit's Earnings per Share (Diluted) for the three months ended in Mar. 2025 was ₩-637.00. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ₩-4,261.00.

Lunit's EPS (Basic) for the three months ended in Mar. 2025 was ₩70.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2025 was ₩-2,394.00.

Lunit's EPS without NRI for the three months ended in Mar. 2025 was ₩-637.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2025 was ₩-2,836.21.

During the past 3 years, the average EPS without NRIGrowth Rate was 10.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was 37.40% per year.

During the past 7 years, Lunit's highest 3-Year average EPS without NRI Growth Rate was 71.00% per year. The lowest was 10.30% per year. And the median was 17.70% per year.


Lunit Earnings per Share (Diluted) Historical Data

The historical data trend for Lunit's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lunit Earnings per Share (Diluted) Chart

Lunit Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Earnings per Share (Diluted)
Get a 7-Day Free Trial -10,981.08 -5,584.52 -851.42 -1,420.00 -2,858.00

Lunit Quarterly Data
Dec18 Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -393.00 -571.00 -507.00 -2,546.00 -637.00

Competitive Comparison of Lunit's Earnings per Share (Diluted)

For the Health Information Services subindustry, Lunit's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lunit's PE Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Lunit's PE Ratio distribution charts can be found below:

* The bar in red indicates where Lunit's PE Ratio falls into.


;
;

Lunit Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Lunit's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2024 is calculated as

Diluted Earnings Per Share (A: Dec. 2024 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-82420.863-0)/28.873
=-2,854.60

Lunit's Earnings Per Share (Diluted) for the quarter that ended in Mar. 2025 is calculated as

Diluted Earnings Per Share (Q: Mar. 2025 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(2027.293-0)/28.961
=70.00

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-4,261.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Lunit  (XKRX:328130) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Lunit Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Lunit's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Lunit Business Description

Traded in Other Exchanges
N/A
Address
374 Gangnam-daero, 4th to 9th Floors, Case Square Gangnam II, Yeoksam-dong, Gangnam-gu, Seoul, KOR, 06241
Lunit Inc is a medical AI software company devoted to providing AI-powered total cancer care. Its products comprise of Lunit INSIGHT CXR, AI solution for Chest x-ray; Lunit INSIGHT MMG, AI solution for Mammography; Lunit SCOPE IO, AI-Powered Biomarker for Immuno-Oncology; and Lunit SCOPE PD-L1, AI Solution for PD-L1 Expression.

Lunit Headlines

No Headlines